These common heterocyclic compound, 55557-52-3, name is 3-Chloropyrazine-2-carbonitrile, its traditional synthetic route has been very mature, but the traditional synthetic route has various shortcomings, such as complicated route, low yield, poor purity, etc, below Introduce a new synthetic route. 55557-52-3
1-[3-(3-Chloro-phenyl)-acryloyl]-piperazine-2-carboxylic acid methyl ester (1.6 g, 5.18 mmol) was mixed with 3-chloro-pyrazine-2-carbonitrile (0.868 g, 6.22 mmol) and triethylamine (1.05 g, 10.36 mmol) in acetonitrile at 90 C. overnight. The reaction mixture was quenched water and extracted with dichloromethane. The product was purified by column chromatography with 50% ethyl acetate in hexanes to give 4-[3-(3-chloro-phenyl)-acryloyl]-3′-cyano-3,4,5,6-tetrahydro-2H-[1,2′]bipyrazinyl-3-carboxylic acid methyl ester (white solid, 1.5 g, 70.3%).
Chemical properties determine the actual use. Each compound has specific chemical properties and uses. We look forward to more synthetic routes in the future to expand reaction routes of 55557-52-3.
Reference:
Patent; AstraZeneca AB; NPS PHARMACEUTICALS; US2007/49578; (2007); A1;,
Pyrazine – Wikipedia,
Pyrazine | C4H4N2 – PubChem